Related references
Note: Only part of the references are listed.Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand
Junyan Han et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Cutting Edge: Protective Effect of CX3CR1+ Dendritic Cells in a Vaccinia Virus Pulmonary Infection Model
Olivia Bonduelle et al.
JOURNAL OF IMMUNOLOGY (2012)
Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways
De-Quan Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
New insights for development of a safe and protective RSV vaccine
Jorge C. G. Blanco et al.
HUMAN VACCINES (2010)
Therapeutic targeting of respiratory syncytial virus G-protein
Lawrence M. Kauvar et al.
IMMUNOTHERAPY (2010)
A Systemic Neutrophil Response Precedes Robust CD8+ T-Cell Activation during Natural Respiratory Syncytial Virus Infection in Infants
Michael V. Lukens et al.
JOURNAL OF VIROLOGY (2010)
Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice
Gertrud U. Radu et al.
JOURNAL OF VIROLOGY (2010)
The host response and molecular pathogenesis associated with respiratory syncytial virus infection
Christine M. Oshansky et al.
FUTURE MICROBIOLOGY (2009)
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients
Ellen J. Collarini et al.
JOURNAL OF IMMUNOLOGY (2009)
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
Lia M. Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway
Christine M. Oshansky et al.
VIRAL IMMUNOLOGY (2009)
IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus
Young-Mok Lee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Viral and host factors in human respiratory syncytial virus pathogenesis
Peter L. Collins et al.
JOURNAL OF VIROLOGY (2008)
Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity
Marina S. Boukhvalova et al.
JOURNAL OF VIROLOGY (2007)
The histopathology of fatal untreated human respiratory syncytial virus infection
Joyce E. Johnson et al.
MODERN PATHOLOGY (2007)
T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis
Virginia Amanatidou et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses
J Harcourt et al.
JOURNAL OF IMMUNOLOGY (2006)
The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children
ML Everard
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model:: Time versus potency
A Mejías et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production
A Dakhama et al.
JOURNAL OF IMMUNOLOGY (2005)
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin
FP Polack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease
G Tal et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyerresponsiveness in a murine RSV model
A Mejías et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P
RA Tripp et al.
JOURNAL OF VIROLOGY (2003)
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo
MN Teng et al.
VIROLOGY (2001)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
JJ Campbell et al.
JOURNAL OF IMMUNOLOGY (2001)
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses
P Fraticelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Leucocyte populations in respiratory syncytial virus-induced bronchiolitis
PK Smith et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2001)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Share Paper
